Loading briefing details...
News Brief
By: PointLine Media Research & Editorial Team
Category:Business,Health,Industry,Science & Environment
August 25, 2026
This webinar is significant because it bridges the gap between complex tumor metabolism and therapeutic development. By addressing the mechanisms of T cell exhaustion, the event provides researchers with the necessary frameworks to improve immunotherapy efficacy, ultimately accelerating the discovery of more effective, metabolic-focused treatments for various cancers.
Creative Biolabs is proud to announce an upcoming webinar titled Modeling T Cell Dysfunction in Tumor Microenvironments, scheduled for September 1, 2026, at 10:00 AM EDT. This virtual event features a keynote presentation by Dr. Greg M. Delgoffe, a distinguished Professor of Immunology and Director of the Tumor Microenvironment Center at the UPMC Hillman Cancer Center. The session will address critical challenges in immuno-oncology, focusing on how the tumor microenvironment (TME) creates metabolically hostile conditions that impair immune cell function and facilitate cancer progression.
As tumors evolve, they establish complex ecosystems characterized by nutrient depletion and immunosuppressive byproducts, which directly contribute to T cell exhaustion and reduced immunotherapy efficacy. Dr. Delgoffe will examine innovative methodologies for modeling these nuanced interactions, emphasizing how advanced preclinical testing services and robust in vivo and in vitro systems can better replicate physiological metabolic stress. These sophisticated tools are essential for researchers aiming to investigate immune suppression and validate new therapeutic targets with greater precision.
This webinar provides an invaluable opportunity for oncology researchers, pharmaceutical professionals, and R&D teams to gain deeper insights into immunometabolism. Attendees will explore how metabolic conditions influence immune-cell behavior and learn practical strategies to enhance the development of next-generation cancer immunotherapies. Interested participants can find further details and registration information on the official Creative Biolabs website.